Ind-Swift Laboratories Limited (INDSWFTLAB) - Total Assets

Latest as of September 2025: Rs15.44 Billion INR ≈ $167.02 Million USD

Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) holds total assets worth Rs15.44 Billion INR (≈ $167.02 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Ind-Swift Laboratories Limited - Total Assets Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's total assets have evolved over time, based on quarterly financial data. Also see INDSWFTLAB stock market capitalisation for the company's overall valuation and market capitalisation.

Ind-Swift Laboratories Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Ind-Swift Laboratories Limited's total assets of Rs15.44 Billion consist of 60.2% current assets and 39.8% non-current assets. Review INDSWFTLAB current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	29.8%
Accounts Receivable	Rs1.65 Billion	11.4%
Inventory	Rs1.14 Billion	7.9%
Property, Plant & Equipment	Rs2.60 Billion	18.1%
Intangible Assets	Rs106.81 Million	0.7%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Ind-Swift Laboratories Limited stock quote for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Ind-Swift Laboratories Limited's current assets represent 60.2% of total assets in 2025, an increase from 39.4% in 2006.
Cash Position: Cash and equivalents constituted 29.8% of total assets in 2025, up from 0.8% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2006.
Asset Diversification: The largest asset category is property, plant & equipment at 18.1% of total assets.

Ind-Swift Laboratories Limited Competitors by Total Assets

Key competitors of Ind-Swift Laboratories Limited based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Ind-Swift Laboratories Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.03	3.57	2.85
Quick Ratio	3.51	3.51	1.78
Cash Ratio	1.91	2.67	0.00
Working Capital	Rs6.34 Billion	Rs4.22 Billion	Rs5.89 Billion

Ind-Swift Laboratories Limited - Advanced Valuation Insights

This section examines the relationship between Ind-Swift Laboratories Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.92
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	-1.5%
Total Assets	Rs14.38 Billion
Market Capitalization	$350.52 Million USD

Valuation Analysis

Below Book Valuation: The market values Ind-Swift Laboratories Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Ind-Swift Laboratories Limited's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual total assets of Ind-Swift Laboratories Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs14.38 Billion ≈ $155.55 Million	-1.51%
2024-03-31	Rs14.60 Billion ≈ $157.94 Million	-19.94%
2023-03-31	Rs18.24 Billion ≈ $197.27 Million	+1.29%
2022-03-31	Rs18.01 Billion ≈ $194.75 Million	-0.97%
2021-03-31	Rs18.18 Billion ≈ $196.66 Million	-2.76%
2020-03-31	Rs18.70 Billion ≈ $202.23 Million	-2.80%
2019-03-31	Rs19.24 Billion ≈ $208.07 Million	-4.89%
2018-03-31	Rs20.23 Billion ≈ $218.78 Million	-5.36%
2017-03-31	Rs21.38 Billion ≈ $231.16 Million	-3.68%
2016-03-31	Rs22.19 Billion ≈ $240.00 Million	-1.10%
2015-03-31	Rs22.44 Billion ≈ $242.66 Million	-3.27%
2014-03-31	Rs23.20 Billion ≈ $250.86 Million	-2.29%
2013-03-31	Rs23.74 Billion ≈ $256.75 Million	+7.66%
2012-03-31	Rs22.05 Billion ≈ $238.49 Million	+26.84%
2011-03-31	Rs17.39 Billion ≈ $188.03 Million	+36.44%
2010-03-31	Rs12.74 Billion ≈ $137.81 Million	+32.73%
2009-03-31	Rs9.60 Billion ≈ $103.83 Million	+19.16%
2008-03-31	Rs8.06 Billion ≈ $87.14 Million	+15.48%
2007-03-31	Rs6.98 Billion ≈ $75.46 Million	+35.71%
2006-03-31	Rs5.14 Billion ≈ $55.60 Million	--

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic

Market Cap

$350.52 Million

Rs32.41 Billion INR

Market Cap Rank

#14207 Global

#703 in India

Share Price

Rs373.25

Change (1 day)

-1.32%

52-Week Range

Rs88.15 - Rs388.55

All Time High

Rs388.55